Scientific title:
How intensively should we treat blood pressure in established cerebral small vessel disease?
University of Cambridge (previously St. George's, University of London)
Principal investigator:
Professor Hugh Markus
Grant value:
Research ID:
TSA BHF 2010/01 (collaboratively funded with British Heart Foundation)
Research area:
Start date:
Friday 1 July 2011
End date:
Wednesday 28 February 2018
80 months
Year awarded:

Disease of the small blood vessels in the brain is an important cause of stroke and is the most common cause of cognitive impairment and dementia. High blood pressure is the major factor causing small vessel disease of the brain. We know that we greatly reduce the chance of this disease if we treat blood pressure (BP) before the disease develops. However, once people have established the disease, we do not know how intensively we should treat BP.

Some doctors believe that, even at this stage, treating BP will reduce progression of the disease. Others believe that by the time well-established disease develops, the brain is unable to cope with any reduction in blood flow caused by BP, and therefore, treating BP too intensively could worsen the disease and in particular, worsen cognition. The only way we can answer this question is by carrying out a clinical trial in a sufficiently large number of individuals.

In this study, we are testing the theory that by treating BP more intensively we will delay progression of the disease. We will also use state-of-the-art MRI imaging techniques to look at the mechanisms by which any beneficial effect of BP occurs. We are using MRI techniques which allow us to look at damage to the brain in a more sensitive way, and also at blood flow in the brain.